Voglio sapere a riguardo di…

24708

Federal Register / Vol. 86, No. 88 / Monday, May 10, 2021 / Rules and Regulations
1310.09 Temporary exemption from registration.

q1 Each person required under 21
U.S.C. 822 and 957 to obtain a registration to manufacture, distribute, import, or export regulated forms of 3,4MDP-2-P methyl glycidate PMK
glycidate, 3,4-MDP-2-P methyl glycidic acid PMK glycidic acid, and alphaphenylacetoacetamide APAA, including regulated chemical mixtures pursuant to 1310.12, is temporarily exempted from the registration requirement, provided that DEA
receives a properly completed application for registration or application for exemption for a chemical mixture containing regulated forms of 3,4-MDP-2-P methyl glycidate PMK glycidate, 3,4-MDP-2-P methyl glycidic acid PMK glycidic acid, or alpha-phenylacetoacetamide APAA
pursuant to 1310.13 on or before 30

days after publication of a rule implementing regulations regarding these three chemicals. The exemption will remain in effect for each person who has made such application until the Administration has approved or denied that application. This exemption applies only to registration; all other chemical control requirements set forth in the Act and parts 1309, 1310, 1313, and 1316 of this chapter remain in full force and effect.
2 Any person who manufactures, distributes, imports or exports a chemical mixture containing regulated forms of 3,4-MDP-2-P methyl glycidate PMK glycidate, 3,4-MDP-2-P methyl glycidic acid PMK glycidic acid, or alpha-phenylacetoacetamide APAA
whose application for exemption is subsequently denied by DEA must obtain a registration with DEA. A
temporary exemption from the registration requirement will also be
provided for those persons whose applications for exemption are denied, provided that DEA receives a properly completed application for registration on or before 30 days following the date of official DEA notification that the application for exemption has been denied. The temporary exemption for such persons will remain in effect until DEA takes final action on their registration application.
5. In 1310.12, in paragraph c, add in alphanumerical order entries for 3,4MDP-2-P methyl glycidate PMK
glycidate, 3,4-MDP-2-P methyl glycidic acid PMK glycidic acid, and alphaphenylacetoacetamide APAA in the table Table of Concentration Limits to read as follows:

1310.12

Exempt chemical mixtures.

c

TABLE OF CONCENTRATION LIMITS
DEA
chemical code no.

3,4-MDP-2-P methyl glycidate PMK glycidate and its optical and geometric isomers.
3,4-MDP-2-P methyl glycidic acid PMK glycidic acid and its salts, optical and geometric isomers, and salts of isomers.
Alpha-phenylacetoacetamide APAA and its optical isomers.

FR Doc. 202109697 Filed 5721; 8:45 am BILLING CODE 441009P

AGENCY FOR INTERNATIONAL
DEVELOPMENT
22 CFR Part 228
AID20200004
RIN 0412AB09

Procurement of Certain Essential Medical Supplies To Address the COVID19 Pandemic khammond on DSKJM1Z7X2PROD with RULES

8515

Chemical mixtures chemical are not Chemical mixtures chemical are not
Not exempt at any concentration.

On October 23, 2020, the United States Agency for International

You may review the docket by searching for Docket ID AID2020

ADDRESSES:

PO 00000

Frm 00010

Fmt 4700

Sfmt 4700

containing any amount of this exempt.
containing any amount of this exempt.

Chemical mixtures containing any amount of this chemical are not exempt.

This rule is effective May 10, 2021. As stated in the October 23, 2020, final rule, the TFR was effective from October 23, 2020, through April 30, 2021. The amendments in this rule are applicable beginning May 1, 2021, after the expiration of the TFR.

Agency for International Development.
ACTION: Final rule; technical amendments.

Jkt 253001

DATES:

AGENCY:

SUMMARY:

Not exempt at any concentration.
Not exempt at any concentration.

Special conditions
Development USAID issued a Temporary Final Rule TFR amending our regulations to allow USAID to waive Source and Nationality rules to provide for increased flexibility, targeting, and speed of procurement of Essential Medical Supplies required to address the COVID19 pandemic worldwide. The TFR was effective through April 30, 2021. This document reverts the amended sections to the text of those sections as they existed prior to the issuance of the TFR, with minor technical updates. This reversion to the original text is applicable upon the expiration of the TFR.

16:22 May 07, 2021

8525

D. Christopher Evans, Acting Administrator.

VerDate Sep<11>2014

8535

Concentration

0004, via the Federal eRulemaking Portal: http www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Greg Marchand, Assistant General Counsel, Office of the General Counsel, USAID, 1300 Pennsylvania Ave. NW, Washington, DC 20523, 2022153409, GCFEDREGMailbox@usaid.gov.
SUPPLEMENTARY INFORMATION: This document affects 22 CFR 228.01, which was amended by the TFR published in the Federal Register on October 23, 2020 85 FR 67443 and subsequently corrected on December 16, 2020 85 FR
81390. The TFR and its subsequent correction revised the definitions in 228.01 by adding a new definition for Essential medical supplies. This document reinstates the definitions in 228.01 exactly as they existed prior to the issuance of the TFR. This document also reverts 22 CFR 228.11 and 228.30, which were also amended by the TFR
published in the Federal Register on October 23, 2020 85 FR 67443. The TFR amended these sections to create a
E:FRFM10MYR1.SGM

10MYR1